Topics / Epidemiology
Weekly issue
Epidemiology Papers of the Week
The top Epidemiology papers of the week: the 20 most important new papers of the past week, ranked by potential impact. A new issue comes out every Monday, covering the previous Monday-to-Sunday week.
- 1
- 2Bridging Microbiology and Public Health Through Simulation-based Learning
To address these points, we created a simulation-based curriculum that places students in an action role during an infectious disease outbreak. Our stand-alone curriculum walks through a historical measles outbreak that introduces outbreak investigation, community communication, and how these depend on microbiological knowledge.
- 3
- 4Variation in Recommendations for Management of Pediatric Fever and Neutropenia Across Databases and Languages: A Systematic Review of Clinical Practice Guidelines
We performed a systematic review and content analysis of CPG to assess the impact of databases searched and publication language on the quantity, quality, and content of recommendations identified for pediatric FN.
- 5
Get papers like these the day they come out, not a week later.
Follow this category- 6
- 7Effectiveness of The 2025-2026 Covid-19 Vaccine Against Covid-19-associated Emergency Department Visits and Hospitalizations Among U.S. Veterans: An Observational Study
We estimated the effectiveness of the 2025-2026 Covid-19 vaccine against Covid-19-associated emergency department visits and hospitalizations among US veterans.
- 8Molecular Profiling and Precision Oncology for Non-Small Cell Lung Cancer in Latin America: Unique Epidemiology, Persistent Barriers, and Paths Toward Equity
In this review, we discuss the unique molecular epidemiology of the region and the challenges of treatment implementation, focusing on the urgent need to integrate new technologies to ensure equitable access to precision oncology.
- 9Global Proposal for The TNM Staging System for Poorly Differentiated Thyroid Cancer
To develop a PDTC-specific staging system. This cohort study analyzed data from the International Aggressive Thyroid Cancer Collaborative Group (IATCCG), including surgically treated patients at 91 centers in 14 countries from January 1984 to January 2026.
- 10Difficult-to-Treat Resistant Pseudomonas Aeruginosa: Resistance Mechanisms and Susceptibility to The Novel Antipseudomonal Β-Lactams
This review examines the evidence linking individual resistance mechanisms to expected in vitro susceptibility, emphasizing the heterogeneity of DTR isolates and the importance of direct susceptibility testing.
- 11
- 12Reframing Disease Elimination: An Update from The Lancet Commission on Chronic Obstructive Pulmonary Disease
This Review revisits that vision, assesses progress since 2022, and calls for a broader commitment to lifelong lung health as an update of the Commission.
- 13
- 14Global, Regional, and National Burden of Gallbladder and Biliary Diseases in 204 Countries and Territories, 1990-2023: A Systematic Analysis for The Global Burden of Disease Study 2023
We aimed to quantify long-term trends and current patterns in prevalence, mortality, and disability associated with gallbladder and biliary diseases across geographies, sexes, and ages.
- 15Development and Validation of A Pre-COPD Score to Predict Incident COPD
We identified individuals without airflow obstruction, defined as pre-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC)≥0.70 and ≥lower limit of normal, from the Copenhagen General Population Study (CGPS)(N = 14,506), Copenhagen City Heart Study (CCHS)(N = 8673), and Genetic Epidemiology for COPD (COPDGene) Study(N = 2982).
- 162026 Global Initiative for Asthma (GINA) Strategy Report: Executive Summary and Key Changes
The Global Initiative for Asthma (GINA) Strategy Report provides a comprehensive, annually updated evidence-based approach to asthma diagnosis, assessment, treatment, and prevention across the lifespan.
- 17
- 18AASLD EXPO: Diagnosis and Management of Hepatitis Delta Virus (HDV) Infection
Considerations for patient selection, treatment regimen, monitoring, assessment of response, and care of patients in special populations are summarized in the document.
- 19Cancer Risks Associated With Germline BARD1 Pathogenic/Likely Pathogenic Variants: A Multicenter Study of 445 Families
We performed a secondary retrospective analysis of multicenter data comprising 445 three-generation pedigrees with confirmed PVs/LPVs from 25 institutions nationwide.
- 20Reimagining COPD Treatment: Are Biologics The Next Frontier?
Growing recognition of disease heterogeneity such as a distinct type-2/eosinophilic endotype as well as advances in biologic agents motivate reassessment of monoclonal antibodies (mAbs) as targeted treatments. This narrative review summarizes evidence from Phase 2 and 3 studies for mAbs in COPD, grouping agents by molecular targets (IL-1β, IL-4/IL-4 Rα/IL-13, IL-5/IL-5 Rα, IL-8, IL-17, IL-33/ST2/RAGE/EGFR, TSLP, TNF-α).